Advertisement

Risk-reducing mastectomy in BRCA mutation carriers: survival is one of the issues—author's reply

  • Bernadette Anna Maria Heemskerk-GerritsenEmail author
  • Maartje Joanneke Hooning
Rebuttal Letter

Notes

References

  1. 1.
    Heemskerk-Gerritsen BAM, Jager A, Koppert LB, Obdeijn AI-M, Collée M, Meijers-Heijboer HEJ, Jenner DJ, Oldenburg HSA, van Engelen K, de Vries J, van Asperen CJ, Devilee P, Blok MJ, Kets CM, Ausems MGEM, Seynaeve C, Rookus MA, Hooning MJ (2019) Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 177(3):723–733CrossRefGoogle Scholar
  2. 2.
    Neven P, Punie K, Wildiers H, Willers N, Van Ongeval C, Van Buggenhout G, Legius E (2019) Risk-reducing mastectomy in BRCA carriers: survival is not the issue. Breast Cancer Res TreatGoogle Scholar
  3. 3.
    Evans DG, Howell SJ, Howell A (2019) Should unaffected female BRCA2 pathogenic variant carriers be told there is little or no advantage from risk reducing mastectomy? Fam Cancer 18(4):377–379CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Erasmus MC Cancer InstituteRotterdamThe Netherlands

Personalised recommendations